Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-031978
Filing Date
2019-08-14
Accepted
2019-08-14 08:39:42
Documents
69
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vcnx-10q_20190630.htm 10-Q 1777100
2 EX-31.1 vcnx-ex311_146.htm EX-31.1 21146
3 EX-31.2 vcnx-ex312_147.htm EX-31.2 20774
4 EX-32.1 vcnx-ex321_148.htm EX-32.1 11256
  Complete submission text file 0001564590-19-031978.txt   5569352

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vcnx-20190630.xml EX-101.INS 1011013
6 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20190630.xsd EX-101.SCH 48520
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vcnx-20190630_cal.xml EX-101.CAL 36832
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vcnx-20190630_def.xml EX-101.DEF 148118
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20190630_lab.xml EX-101.LAB 356391
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20190630_pre.xml EX-101.PRE 278866
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38624 | Film No.: 191023014
SIC: 2834 Pharmaceutical Preparations